These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 18848664

  • 1. Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor.
    Evens N, Bosier B, Lavey BJ, Kozlowski JA, Vermaelen P, Baudemprez L, Busson R, Lambert DM, Van Laere K, Verbruggen AM, Bormans GM.
    Nucl Med Biol; 2008 Oct; 35(7):793-800. PubMed ID: 18848664
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
    Evens N, Muccioli GG, Houbrechts N, Lambert DM, Verbruggen AM, Van Laere K, Bormans GM.
    Nucl Med Biol; 2009 May; 36(4):455-65. PubMed ID: 19423014
    [Abstract] [Full Text] [Related]

  • 3. A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo.
    Lunn CA, Fine JS, Rojas-Triana A, Jackson JV, Fan X, Kung TT, Gonsiorek W, Schwarz MA, Lavey B, Kozlowski JA, Narula SK, Lundell DJ, Hipkin RW, Bober LA.
    J Pharmacol Exp Ther; 2006 Feb; 316(2):780-8. PubMed ID: 16258021
    [Abstract] [Full Text] [Related]

  • 4. Facile and high-yield synthesis of N-(4-diethylamino)benzyl-4-[¹¹C]methoxy-N-(p-tolyl)benzenesulfonamide as a new potential PET selective CB2 radioligand.
    Gao M, Xu J, Wang M, Zheng QH.
    Appl Radiat Isot; 2014 Aug; 90():181-6. PubMed ID: 24768996
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
    Mathews WB, Murugesan N, Xia J, Scheffel U, Hilton J, Ravert HT, Dannals RF, Szabo Z.
    J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
    Gao M, Mock BH, Hutchins GD, Zheng QH.
    Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Radiosynthesis and radiopharmacological evaluation of [N-methyl-11C]Org 34850 as a glucocorticoid receptor (GR)-binding radiotracer.
    Wuest F, Kniess T, Henry B, Peeters BW, Wiegerinck PH, Pietzsch J, Bergmann R.
    Appl Radiat Isot; 2009 Feb; 67(2):308-12. PubMed ID: 19071028
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R, Müller Herde A, Haider A, Krämer SD, Weber M, Schibli R, Ametamey SM, Mu L.
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [Abstract] [Full Text] [Related]

  • 13. Development of new carbon-11 labelled radiotracers for imaging GABAA- and GABAB-benzodiazepine receptors.
    Moran MD, Wilson AA, Elmore CS, Parkes J, Ng A, Sadovski O, Graff A, Daskalakis ZJ, Houle S, Chapdelaine MJ, Vasdev N.
    Bioorg Med Chem; 2012 Jul 15; 20(14):4482-8. PubMed ID: 22717238
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptors.
    Kassiou M, Dannals RF, Liu X, Wong DF, Ravert HT, Scheffel UA.
    Bioorg Med Chem; 2005 Jun 01; 13(11):3623-6. PubMed ID: 15862990
    [Abstract] [Full Text] [Related]

  • 15. In vivo labeling of endothelin receptors with [(11)C]L-753,037: studies in mice and a dog.
    Aleksic S, Szabo Z, Scheffel U, Ravert HT, Mathews WB, Kerenyi L, Rauseo PA, Gibson RE, Burns HD, Dannals RF.
    J Nucl Med; 2001 Aug 01; 42(8):1274-80. PubMed ID: 11483691
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
    Yao BB, Hsieh G, Daza AV, Fan Y, Grayson GK, Garrison TR, El Kouhen O, Hooker BA, Pai M, Wensink EJ, Salyers AK, Chandran P, Zhu CZ, Zhong C, Ryther K, Gallagher ME, Chin CL, Tovcimak AE, Hradil VP, Fox GB, Dart MJ, Honore P, Meyer MD.
    J Pharmacol Exp Ther; 2009 Jan 01; 328(1):141-51. PubMed ID: 18931146
    [Abstract] [Full Text] [Related]

  • 20. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand.
    Airaksinen AJ, Jablonowski JA, van der Mey M, Barbier AJ, Klok RP, Verbeek J, Schuit R, Herscheid JD, Leysen JE, Carruthers NI, Lammertsma AA, Windhorst AD.
    Nucl Med Biol; 2006 Aug 01; 33(6):801-10. PubMed ID: 16934699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.